SLE ANTIBODIES TO NEURONS AND LYMPHOCYTES: PATHOBIOLOGY
系统性红斑狼疮神经元和淋巴细胞抗体:病理学
基本信息
- 批准号:3152006
- 负责人:
- 金额:$ 22.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1981
- 资助国家:美国
- 起止时间:1981-07-01 至 1987-03-31
- 项目状态:已结题
- 来源:
- 关键词:T lymphocyte antibody formation antigen antibody reaction autoradiography blood brain barrier blood tests cell mediated cytotoxicity cell population study cerebrospinal fluid gel electrophoresis human subject immunoregulation lymphocyte membrane activity nervous system disorder neurons orphan disease /drug radiotracer scintillation spectrometry surface antigens systemic lupus erythematosus tissue /cell culture
项目摘要
Central nervous system dysfunction is a common occurrence in systemic lupus
erythematosus, and it is one of the serious life-threatening manifestations
of the disease. Immune complex-mediated vasculitis, the mechanism
responsible for tissue damage in most organ systems, is rarely found in the
brain of patients with CNS disease. A major research effort in this
laboratory has been the investigation of the role of antibodies reactive
with neuronal cells from human brain in the pathogenesis of lupus
neuropsychiatric manifestations. Our studies have demonstrated that most
lupus patients have circulating antibodies reactive with human neurons, and
many of those antibodies are cross-reactive with antigens on human
lymphocytes. A pathogenetic role for those antibodies is suggested by the
close association of antineuronal antibody within the central nervous
system and active CNS lupus. In this application we are proposing more
detailed analysis of the disease-producing potential of the neuron and
lymphocyte reactive antibodies. Our aims are to understand how these
antibodies get into the nervous system and to define the antigens with
which they react. We will determine if the antibodies are produced locally
within the central nervous system or if they enter from the serum through a
leak in the blood-brain barrier. We will investigate their reactivity with
the neurotransmitter receptors that regulate brain function, and we will
utilize the neuron and lymphocyte reactive antibodies to physically
characterize the antigens shared by those two cell types and analyze their
distribution on lymphocyte subpopulations as a probe into the potential
link between altered immune regulation and nervous system dysfunction that
characterize SLE.
中枢神经系统功能障碍是系统性狼疮的常见病
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Neuropsychologic deficits and antineuronal antibodies in pediatric systemic lupus erythematosus.
儿童系统性红斑狼疮的神经心理缺陷和抗神经元抗体。
- DOI:
- 发表时间:1990
- 期刊:
- 影响因子:3.7
- 作者:Papero,PH;Bluestein,HG;White,P;Lipnick,RN
- 通讯作者:Lipnick,RN
Very late activation antigens (VLA) are human leukocyte-neuronal crossreactive cell surface antigens.
- DOI:10.1084/jem.164.2.393
- 发表时间:1986-08-01
- 期刊:
- 影响因子:0
- 作者:Pischel KD;Bluestein HG;Woods VL Jr
- 通讯作者:Woods VL Jr
Antineuronal antibodies in systemic lupus erythematosus.
系统性红斑狼疮中的抗神经元抗体。
- DOI:10.1002/art.1780250711
- 发表时间:1982
- 期刊:
- 影响因子:0
- 作者:Bluestein,HG;WoodsJr,VL
- 通讯作者:WoodsJr,VL
Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2.
- DOI:10.4049/jimmunol.138.1.226
- 发表时间:1987-01
- 期刊:
- 影响因子:4.4
- 作者:K. Pischel;M. Hemler;C. Huang;H. Bluestein;V. Woods
- 通讯作者:K. Pischel;M. Hemler;C. Huang;H. Bluestein;V. Woods
Antigenic polymorphism of human very late activation protein-2 (platelet glycoprotein Ia-IIa). Platelet alloantigen Hca.
人极晚激活蛋白-2(血小板糖蛋白 Ia-IIa)的抗原多态性。
- DOI:10.1172/jci113984
- 发表时间:1989
- 期刊:
- 影响因子:0
- 作者:WoodsJr,VL;Pischel,KD;Avery,ED;Bluestein,HG
- 通讯作者:Bluestein,HG
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HARRY G BLUESTEIN其他文献
HARRY G BLUESTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HARRY G BLUESTEIN', 18)}}的其他基金
MULTIPURPOSE ARTHRITIS & MUSCULOSKELETAL DISEASE CENTER
多用途关节炎
- 批准号:
2006220 - 财政年份:1991
- 资助金额:
$ 22.62万 - 项目类别:
MULTIPURPOSE ARTHRITIS & MUSCULOSKELETAL DISEASE CENTER
多用途关节炎
- 批准号:
2882268 - 财政年份:1991
- 资助金额:
$ 22.62万 - 项目类别:
MULTIPURPOSE ARTHRITIS & MUSCULOSKELETAL DISEASE CENTER
多用途关节炎
- 批准号:
2667806 - 财政年份:1991
- 资助金额:
$ 22.62万 - 项目类别:
MULTIPURPOSE ARTHRITIS & MUSCULOSKELETAL DISEASE CENTER
多用途关节炎
- 批准号:
6164019 - 财政年份:1991
- 资助金额:
$ 22.62万 - 项目类别:
SLE ANTIBODIES TO NEURONS & LYMPHOCYTES: PATHOBIOLOGY
针对神经元的 SLE 抗体
- 批准号:
3155738 - 财政年份:1981
- 资助金额:
$ 22.62万 - 项目类别:
SLE ANTIBODIES TO NEURONS & LYMPHOCYTES--PATHOBIOLOGY
针对神经元的 SLE 抗体
- 批准号:
3155741 - 财政年份:1981
- 资助金额:
$ 22.62万 - 项目类别:
SLE ANTIBODIES TO NEURONS & LYMPHOCYTES: PATHOBIOLOGY
针对神经元的 SLE 抗体
- 批准号:
3155736 - 财政年份:1981
- 资助金额:
$ 22.62万 - 项目类别:
ANTIBODIES TO NEURONS AND LYMPHOCYTES--PATHOLOGY
神经元和淋巴细胞抗体——病理学
- 批准号:
3155739 - 财政年份:1981
- 资助金额:
$ 22.62万 - 项目类别:
相似海外基金
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9981001 - 财政年份:2017
- 资助金额:
$ 22.62万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9751102 - 财政年份:2017
- 资助金额:
$ 22.62万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9397073 - 财政年份:2017
- 资助金额:
$ 22.62万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
10223410 - 财政年份:2017
- 资助金额:
$ 22.62万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
- 批准号:
7951676 - 财政年份:2008
- 资助金额:
$ 22.62万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
- 批准号:
7606036 - 财政年份:2006
- 资助金额:
$ 22.62万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7375053 - 财政年份:2005
- 资助金额:
$ 22.62万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7201220 - 财政年份:2004
- 资助金额:
$ 22.62万 - 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
- 批准号:
6980810 - 财政年份:2003
- 资助金额:
$ 22.62万 - 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
- 批准号:
6419444 - 财政年份:2000
- 资助金额:
$ 22.62万 - 项目类别: